What is Nabla?
Nabla provides doctors with an AI-powered tool that generates clinical notes from patient consultations. Headquartered in Paris, Ile-de-France, France, the company is at the forefront of leveraging artificial intelligence to alleviate the administrative burden on healthcare professionals. By automating the transcription and summarization of patient encounters, Nabla aims to enhance physician efficiency and improve the quality of patient care. The company's technology addresses a critical need for digital solutions in the healthcare industry, positioning it for significant expansion.
How much funding has Nabla raised?
Nabla has raised a total of $112.8M across 3 funding rounds:
Series A
$18.8M
Series B
$24M
Series C
$70M
Series A (2020): $18.8M, investors not publicly disclosed
Series B (2024): $24M led by Cathay Innovation and Zebox Ventures
Series C (2025): $70M supported by HV Capital, Highland Europe, Cathay Innovation, and BC Mgmt
Key Investors in Nabla
Highland Europe
Highland Europe is a venture capital firm that provides growth capital to exceptional teams, focusing on building collaborative and successful relationships with product-led companies across Europe and Israel. They specialize in software and consumer sectors.
Cathay Innovation
Cathay Innovation is a global venture capital firm that supports entrepreneurs by connecting them to a worldwide ecosystem, investing in multi-stage startups making a positive impact through technology, with a focus on AI and healthcare.
HV Capital
HV Capital is an independent venture funding firm that invests in companies in the early stages of business, with offices in Munich and Berlin, Germany.
What's next for Nabla?
With its recent major strategic investment, Nabla is poised for accelerated growth and product development. The substantial capital infusion, part of its $112.8M in total financing, will likely be directed towards expanding its engineering team, enhancing its AI capabilities, and broadening its market reach, particularly in key international markets. This strategic backing suggests a focus on scaling operations and solidifying its position as a leader in AI-powered medical documentation solutions. Future developments may include deeper integration with existing electronic health record systems and the introduction of new AI-driven features to further support clinicians.
See full Nabla company page
